Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar Belakang: Risiko Non-Alcoholic Fatty Liver Disease NAFLD meningkat pada pasien dengan diabetes melitus DM tipe 2. Prevalensi dan faktor-faktor yang berhubungan dengan peningkatan risiko NAFLD pada populasi DM di Indonesia belum pernah diteliti. Profil derajat fibrosis pada populasi ini juga masih belum diketahui. Tujuan: Mengetahui perbedaan profil pasien DM dengan atau tanpa NAFLD serta derajat fibrosisnya. Metode: Penelitian dikerjakan secara potong lintang terhadap pasien DM tipe 2 dewasa yang berobat di poliklinik endokrin metabolik RSCM. Pengambilan sampel dilakukan secara konsekutif. Data yang dikumpulkan mencakup usia, lama diabetes, indeks masa tubuh IMT , lingkar pinggang, kadar HDL, trigliserida, dan HbA1C. Ultrasonografi abdomen dikerjakan pada semua pasien untuk menentukan adanya NAFLD. Pasien dengan NAFLD lalu menjalani pemeriksaan elastografi transien untuk menilai derajat fibrosis. Uji Chi Square atau Fischer's-Exact digunakan untuk analisis bivariat dan regresi logistik digunakan untuk analisis multivariat. Hasil Penelitian: Sebanyak 186 pasien dianalisis dalam studi ini, dengan 84 pasien 45,2 terbukti mengalami NAFLD. Elastografi transien berhasil dikerjakan pada 68 pasien NAFLD, dengan 17 pasien 25,0 terbukti mengalami fibrosis berat. Analisis univariat menunjukan perbedaan signifikan IMT PR=1,878; 95 CI= 1,296-2,721.

---

Background: Risk of Non Alcoholic Fatty Liver Disease NAFLD is increased in patients with type 2 diabetes. Prevalence and factors related to the increased risk of NAFLD in diabetic patients in Indonesia are currently unknown. Data regarding fibrosis profile in this population is also unknown.

Aim: To understand the prevalence and fibrosis profile of Non Alcoholic Fatty Liver Disease in diabetes mellitus and factors associated with it.

Methods: This study was a cross sectional study on diabetic patients treated in the endocrinology and metabolic clinic of Cipto Mangunkusumo Hospital. Sampling was done consecutively. Data collected comprised of age, duration of diabetes, body mass index BMI, waist circumference, HDL, triglyceride, and HbA1C. Abdominal ultrasonography was conducted to every patient to determine the presence of NAFLD. Patients with NAFLD underwent transient elastography to assess their degree of liver fibrosis. Collected data were analyzed in univariate and multivariate manner.

Study Results: We analyzed 186 patients with diabetic. NAFLD were diagnosed in 84 patients 45,2. Transient elastography were carried out in 68 patients, with advanced fibrosis were found in 17 patients 25,0. Univariate analysis showed significant differences between BMI PR 1,878 95 CI 1,296 2,721 p"

"Latar Belakang: Pemahaman tentang non-alcoholic fatty pancreas disease NAFPD dan makna klinisnya perlu terus ditingkatkan mengingat NAFPD diduga dapat berlanjut menjadi pankreatitis kronik dan memicu terjadinya kanker pankreas. NAFPD berhubungan erat dengan diabetes melitus tipe 2 DMT2 dan pasien diabetes berisiko 2x lipat untuk mengalami kanker pankreas. Proporsi dan faktor-faktor yang berhubungan dengan NAFPD pada populasi DMT2 belum pernah diteliti.Tujuan: Mengetahui proporsi dan faktor-faktor yang berhubungan dengan NAFPD pada populasi DM tipe 2.Metode: Pasien DMT2 dewasa yang berobat di poliklinik metabolik endokrin Rumah Sakit Cipto Mangunkusumo RSCM direkrut secara konsekutif pada studi potong lintang ini. Data usia, jenis kelamin, lama DM, komorbid, obat-obatan, lingkar pinggang, profil lipid dan HbA1C dikumpulkan. Ultrasonografi hepatobilier dilakukan pada setiap pasien untuk menentukan adanya NAFPD dan non-alcoholic fatty liver disease NAFLD . Hubungan NAFPD dengan parameter usia, jenis kelamin, lama DM, hipertensi, NAFLD, trigliserida dan HbA1C diuji kemaknaanya.Hasil Penelitian: Dari 171 pasien DMT2 yang direkrut dalam studi ini didapatkan proporsi NAFPD sebesar 48,5% (95%IK=41,2-55,9%). Analisis univariat menunjukkan perbedaan signifikan di antara kelompok NAFPD dan non-NAFPD dalam hal proporsi NAFLD (PR=1,96; 95%IK=1,41-2,74; p<0,001) dan hipertrigliseridemia (PR=1,38; 95%IK=1,02-1,86; p=0,042). Pada analisis multivariat usia lanjut (OR=2,15; 95%IK=1,10-4,23), NAFLD (OR=3,65; 95%IK=1,90-6,99) dan hipertrigliseridemia (OR=2,03; 95%IK=1,02-4,05) menunjukkan hubungan yang signifikan dengan kejadian NAFPD. Tidak ditemukan hubungan yang bermakna antara jenis kelamin, lama DM, hipertensi, serta kadar HbA1C dengan kejadian NAFPD.Kesimpulan: Proporsi NAFPD pada populasi DMT2 sebesar 48,5%. Usia lanjut, NAFLD dan hipertrigliseridemia merupakan faktor-faktor yang berhubungan dengan kejadian NAFPD pada pasien DMT2.

---

Background: Understanding of non alcoholic fatty pancreas disease NAFPD and its clinical significance needs to be continuously improved as NAFPD might allegedly develop into chronic pancreatitis and further leads to pancreatic cancer. NAFPD is strongly associated with type 2 diabetes mellitus T2DM and long term T2DM is associated with a 1.5 to 2.0 fold increase in the risk of pancreatic cancer. The proportion of NAFPD and its associated factors in T2DM population has not been well investigated.

Aim: To investigate the proportion of NAFPD and its associated factors in type 2 DM population.

Methods: Adult T2DM patients who visited Diabetes Clinic, Cipto Mangunkusumo Hospital were consecutively recruited in this cross sectional study. Information about age, sex, duration of diabetes, komorbidities, medication, waist circumference, lipid profile and HbA1C were collected. Abdominal ultrasonography was performed on each subject to diagnose NAFPD and non alcoholic fatty liver disease NAFLD . Association of NAFPD with age, sex, duration of diabetes, hypertension, NAFLD, triglyceride and HbA1C were examined.

Study Results: From total of 171 T2DM patients in this study, the proportion of NAFPD was 48.5% (95%CI= 41.2 to 55.9%). Univariate analysis showed significant differences between NAFPD and non-NAFPD group regarding proportion of NAFLD (PR=1.96; 95%CI=1.41-2.74; p<0.001) and hypertriglyceridemia (PR=1.38; 95%CI=1.02-1.86; p=0.042). On multivariate analysis older age (OR=2.15; 95%CI=1.10-4.23), NAFLD (OR=3.65; 95%CI=1.90-6.99), and hypertriglyceridemia (OR=2.03; 95%CI=1.02-4.05) showed significant association with NAFPD. There were no significant association found among sex, duration of diabetes, hypertension and high levels of HbA1C with NAFPD.

Conclusion: The proportion of NAFPD in T2DM population is 48.5%. Older age, NAFLD and hypertriglyceridemia are associated factors of NAFPD in T2DM patient."

"Background: the risk of Non Alcoholic Fatty Liver Disease (NAFLD) is increasing in patients with type 2 diabetes. Prevalence and factors related to the increased risk of NAFLD in diabetic patients in Indonesia has never been studied before. Data regarding the profile of fibrosis in the population has also been unknown. This study aimed to identify the difference on the profile of diabetic patients with and without NAFLD as well as the degree of fibrosis.Methods: the study was conducted using a cross sectional method in type 2 diabetic patients who were treated at the outpatient clinic of endocrinology and metabolic division in Cipto Mangunkusumo Hospital. Sampling was done consecutively. Collected data comprised of age, duration of diabetes, body mass index (BMI), waist circumference, HDL, triglyceride, and HbA1C levels. Abdominal ultrasonography was conducted for all patients to determine the presence of NAFLD. Patients with NAFLD were subsequently underwent transient elastography in order to assess their degree of liver fibrosis. Chi-square or Fishers Exact tests were used for bivariate analysis and logistic regression was used for multivariate analysis.Results: as many as 186 patients were analyzed in the study and 84 patients (45.2%) were demonstrated to have NAFLD. Transient elastography examinations were carried out in 68 patients and 17 patients (25.0%) were found with severe fibrosis. Univariate analysis showed significant differences on BMI (PR=1.878; 95%CI= 1.296 2.721; p<0.001) and waist circumference (PR=2.368; 95%CI= 1.117 5.017; p=0.018) between patients with and without NAFLD. However, the multivariate test showed that BMI was the only factor that had a significance difference between both groups (OR=2.989; 95%CI=1.625-5.499; p<0.001).Conclusion: prevalence of NAFLD among type 2 diabetic patients in Cipto Mangunkusumo Hospital has reached 45.2% and 25.0% among them had severe fibrosis. BMI is the only factor found to be associated with the occurrence of NAFLD."

"Latar belakang : Seiring dengan semakin efektifnya terapi Antiretroviral (ARV) pasien HIV memiliki harapan hidup lebih lama, morbiditas dan mortalitas penyakit HIV yang tidak berhubungan dengan Acquired Immunodeficiency Syndrome semakin meningkat. Non-alcoholic Fatty Liver Disease (NAFLD) telah dikenali sebagai penyakit hati tersering yang mempengaruhi lebih dari seperempat jumlah populasi global dan jumlahnya semakin meningkat di Indonesia. Pasien yang terinfeksi HIV memiliki risiko lebih tinggi untuk terkena NAFLD. Penelitian ini bertujuan untuk mendapatkan informasi tentang prevalensi dan faktor yang berhubungan dengan NAFLD pada pasien HIV dalam pengobatan antiretroviral (ARV) tanpa hepatitis viral kronis. Metode: Penelitian ini merupakan studi potong lintang yang melibatkan pasien HIV dalam pengobatan ARV tanpa koinfeksi virus hepatitis yang berobat di poliklinik Kelompok Studi Khusus (POKDISUS) Rumah Sakit Cipto Mangunkusumo Jakarta. NAFLD didefinisikan sebagai perlemakan di jaringan hati yang dibuktikan oleh pemeriksaan imaging transient elastography dengan Controlled Attenuation Parameter (CAP) setidaknya 238 dB/m. Perkiraan faktor-faktor yang berhubungan dengan NAFLD dianalisis dengan regresi logistik bivariat dan multivariat. Hasil: Pada penelitian ini secara keseluruhan didapatkan 105 subyek pasien HIV yang direkrut secara konsekutif. Prevalensi NAFLD didapatkan 52,4% (95% CI ±9,55). Faktor-faktor yang berhubungan dengan NAFLD pada populasi ini adalah hipertensi (PR = 3,755; 95% CI 1,218-11,575; p = 0,021) dan Index Massa Tubuh (IMT) (PR = 1,212 95% CI 1,051-1,396; p = 0,008). Faktor terkait HIV seperti CD4+ nadir, lama mendapat terapi ARV didapatkan tidak terkait NAFLD. Kesimpulan: Prevalensi NAFLD pada pasien HIV di Indonesia tinggi. NAFLD didapatkan berkaitan dengan hipertensi dan IMT, namun tidak dengan faktor-faktor terkait HIV. Penapisan non invasif untuk NAFLD sebaiknya diimplementasikan pada populasi ini untuk intervensi awal dan pencegahan komplikasi.

---

Background: As HIV-infected persons experience longer life expectancies, other cause of morbidity and mortality among this group are increasingly being identified. Non-alcoholic fatty liver disease (NAFLD) has been recognized as the most common liver disease affecting more than a quarter of global population and increasing number in Indonesia. HIV-infected persons are at an increased risk of having NAFLD. This study aimed to inform prevalence and factors associated with NAFLD in HIV-infected patients without chronic viral hepatitis on antiretroviral therapy (ARV). Methods: A cross sectional study of HIV-infected person on ARV without hepatitis co-infection was done in HIV Integrated Clinic Cipto Mangunkusumo Hospital, Jakarta. NAFLD was defined as having at least 238 dB/m in transient elastography with associated Controlled Attenuation Parameter (CAP) examination. Bivariate and multivariate logistic regression analysis were applied to estimate factors associated with NAFLD Results: A total of 105 consecutive HIV infected person were included in the study analyzed. The prevalence of NAFLD was 52.4% (95% CI ±9.55). Factors related to NAFLD in this population were hypertension (PR = 3.755; 95% CI 1.218-11.575; p = 0.021) and Body Mass Index (BMI) (PR = 1.212 95% CI 1.051-1.396; p = 0.008). HIV specific variables such as nadir CD4, duration of ARV were not associated with NAFLD. Conclusion : There was a high prevalence of NAFLD among Indonesian person infected with HIV. NAFLD was associated with BMI and hypertension, but not with HIV related factors. Non-invasive screening for NAFLD should be implemented in this populaton to establish early intervention and prevent complication"

"Latar Belakang : Disbiosis mikrobiota usus dianggap berperan pada progresifitas NAFLD. Penelitian mengenai mikrobiota usus pada pasien NAFLD masih sedikit dan menunjukkan hasil yang berbeda. Tujuan : Mengetahui profil mikrobiota usus pada pasien NAFLD dengan derajat fibrosis hati. Metode : Penelitian menggunakan desain potong lintang, dengan menggunakan sampel pasien NAFLD di Rumah Sakit Cipto Mangunkusumo, periode waktu Maret – Juli 2018. Pemeriksaan sampel feses secara konsekutif dilakukan dengan menggunakan alat isolasi DNA (Tiangen) dan quantitative real-time polymerase chain reaction (Fast 7500) untuk menghitung jumlah mikrobiota dinyatakan dalam copy number DNA/gram feses (Bacteroides, Lactobacillus and Bifidobacteria). Sedangkan pemeriksaan fibrosis hati dengan menggunakan alat transient elastography (FibroScan® 502 Touch). Analisis statistik dilakukan menggunakan analisis bivariat dengan menggunakan uji chi-square. Hasil : Dari 60 pasien NAFLD, didapatkan 35 pasien dengan fibrosis non signifikan dan 25 pasien dengan fibrosis signifikan. Kebanyakan pasien merupakan penderita diabetes melitus (85%), dislipidemia (58,3%), obesitas (58,3%), dan obesitas sentral (90%). Didapatkan jumlah Bacteroides (483.000 kopi unit DNA/gram feses) paling banyak dibandingkan dengan Lactobacillus (100.800 kopi unit DNA/gram feses) dan Bifidobacteria  (12.110 kopi unit DNA/gram feses). Dari ketiga mikrobiota tersebut terdapat peningkatan bermakna proporsi Bacteroides pada kelompok fibrosis signifikan (81%) dibandingkan dengan fibrosis non signifikan (19%). Begitupula dengan Lactobacillus yang jumlahnya lebih banyak pada fibrosis signifikan. Sedangkan pada Bifidobacteria, proporsi pada fibrosis signifikan lebih rendah dibandingkan fibrosis non signifikan. Simpulan : Terdapat perubahan komposisi mikrobiota usus pada pasien NAFLD. Proporsi Bacteroides juga meningkat pada kelompok fibrosis signifikan.

---

Background: Dysbiosis of the gut microbiota has been considered to have a role in NAFLD progression. However, there is still lack of studies regarding this phenomenon.

Aim of the study: To find the difference of gut microbiota profile in NAFLD patient based on the stages of liver fibrosis.

Patients and Methods: A cross sectional study was conducted at Dr. Cipto Mangunkusumo Hospital which is the largest tertiary refferal center hepatobiliary outpatient’s clinic. Human fecal samples from NAFLD patients who came to outpatient clinic were collected consecutively. The stool sample examination was performed using isolation DNA kit (Tiangen) and quantitative real-time polymerase chain reaction (Fast 7500) was used to measure total bacterial counts (Bacteroides, Lactobacillus and Bifidobacteria). Clinical and laboratory data, Food Frequency Questionare (FFQ) were also collected. The stage of fibrosis were diagnosed based on transient elastography (FibroScan® 502 Touch). Statistical analysis including bivariate analysis were performed using SPSS version 20.

Results: Of 60 human fecal samples, there are 35 patients had non significant fibrosis and 25 patients had significant fibrosis and consist of 46.7% male and 53.3% female with the median age is 56 years old. Most patient have diabetes (85%) dyslipidemia (58.3%), obesity (58.3%), and central obesity (90%).  The Bacteroides count (483000) was higher when compared to Lactobacillus (100800) and Bifidobacteria (12110). Of these three microbiota, the proportion of Bacteroides was higher in significant fibrosis group when compared to non significant fibrosis group. Patient with significant fibrosis was also has a higher proportion of Lactobacillus compared to non significant fibrosis group (7000 vs 2050). In contrast, the proportion of Bifidobacteria was lower in significant fibrosis group (22) when compared to non significant fibrosis group (95).

Conclusion: There is a dysbiosis of gut microbiota in NAFLD patients. Bacteroides as a gram-negative microbiota that produces LPS is significantly increased with fibrosis stage, that may play a role in NAFLD progression. "

"Latar Belakang: Non alcoholic fatty liver disease (NAFLD) merupakan kondisi perlemakan hati yang merupakan salah satu faktor risiko karsinoma hepatoselular (KSH). NAFLD melibatkan berbagai faktor dalam patogenesisnya, salah satunya mikrobiota saluran cerna. Disbiosis mikrobiota saluran cerna dianggap sebagai faktor utama dalam peristiwa disregulasi sistem imun dan inflamasi pada patogenesis NAFLD.Tujuan: Studi ini bertujuan untuk melihat profil dan konfigurasi mikrobiota saluran cerna pasien dengan NAFLD dan pengaruhnya terhadap nilai kondisi fibrosis dan stratosis hati yang tercermin dalam nilai controlled attenuation parameter (CAP) dan transient elastography (TE).Metode: Dilakukan studi potong lintang analitik terhadap 37 pasien dengan NAFLD yang memenuhi kriteria inklusi di Rumah Sakit Cipto Mangunkusumo pada Desember 2018 hingga Maret 2019. Dilakukan anamnesis, wawancara food recall, pemeriksaan fisik, pemeriksaan laboratorium, pemeriksaan CAP-TE, dan pengambilan sampel feses pada pasien subjek penelitian. Mikrobiota saluran cerna disekuensing dengan Next-Generation Sequencing (NGS) platform Miseq (Illumina).Hasil: NAFLD lebih dominan pada wanita dan penderita penyakit sindrom metabolik. Firmicutes, Bacteroidetes, dan Proteobacteria berturut-turut merupakan filum dengan proporsi terbesar. Disbiosis mikrobiaota saluran cerna didapatkan pada separuh dari sampel subjek penelitian. Rasio Firmicutes/Bacteroidetes (RFB) pada setiap pasien berbeda-beda dan tidak berkorelasi secara signifikan terhadap variabel sindrom metabolik. Diversitas mikrobiota saluran cerna didapatkan menurun pada pasien NAFLD dengan trigliserida tinggi dan obesitas sentral.Simpulan: Sejumlah mikrobiota saluran cerna pada tingkat taksonomi yang berbeda memiliki korelasi positif maupun negatif terhadap fibrosis dan steatosis.

---

Background: Non alcoholic fatty liver disease (NAFLD) is fatty liver condition that can lead to hepatocellular carcinoma (HCC). NAFLD is multifactorial component in its pathogenesis, one of which is gut microbiota. Dysbiosis of gut microbiota is considered as main factor in the dysregulation of immune system and inflammatory condition in the pathogenesis of NAFLD.

Aim: This study aim to investigate the profile and configuration of gut microbiota in patient with NAFLD dan its correelation withfibrosis and steatosis condition as reflected in controlled attenuation parameter (CAP) dan transient elastography (TE) value.

Method: cross sectional study was done upon 37 NAFLD patients in Cipto Mangunkusumo National General Hospital from December 2018 to March 2019. All subjects undergone food recall examination, physical and laboratory examination, CAP-TE value measurement, and fecal sample examination. The gut microbiota was investigated through 16s RNA sequensing by Next-Generation Sequencing (NGS) platform Miseq (Illumina).

Result: NAFLD was predominant in female subjects and those with metabolic syndrome. Firmicutes, Bacteroidetes, dan Proteobacteria was the predominant phylum consecutively. Dysbiosis was appeared in half of the study subjects. The Ratio of Firmicutes/Bacteroidetes was different in each patients and has no significnat correlation with metabolic syndrome variables. The diversity of gut microbiota was decresed in NAFLD patients with high tryglicerides and central obesity.

Conclusion: Certain gut microbiota at different taxonomy level have positive and negative correlation with fibrosis and steatosis."

"

Latar Belakang: Non alcoholic fatty liver disease (NAFLD) merupakan kondisi perlemakan hati yang merupakan salah satu faktor risiko karsinoma hepatoselular (KSH). NAFLD melibatkan berbagai faktor dalam patogenesisnya, salah satunya mikrobiota saluran cerna. Disbiosis mikrobiota saluran cerna dianggap sebagai faktor utama dalam peristiwa disregulasi sistem imun dan inflamasi pada patogenesis NAFLD.

Tujuan: Studi ini bertujuan untuk melihat profil dan konfigurasi mikrobiota saluran cerna pasien dengan NAFLD dan pengaruhnya terhadap nilai kondisi fibrosis dan stratosis hati yang tercermin dalam nilai controlled attenuation parameter (CAP) dan transient elastography (TE).

Metode: Dilakukan studi potong lintang analitik terhadap 37 pasien dengan NAFLD yang memenuhi kriteria inklusi di Rumah Sakit Cipto Mangunkusumo pada Desember 2018 hingga Maret 2019. Dilakukan anamnesis, wawancara food recall, pemeriksaan fisik, pemeriksaan laboratorium, pemeriksaan CAP-TE, dan pengambilan sampel feses pada pasien subjek penelitian. Mikrobiota saluran cerna disekuensing dengan Next-Generation Sequencing (NGS) platform Miseq (Illumina).

Hasil: NAFLD lebih dominan pada wanita dan penderita penyakit sindrom metabolik. Firmicutes, Bacteroidetes, dan Proteobacteria berturut-turut merupakan filum dengan proporsi terbesar. Disbiosis mikrobiaota saluran cerna didapatkan pada separuh dari sampel subjek penelitian. Rasio Firmicutes/Bacteroidetes (RFB) pada setiap pasien berbeda-beda dan tidak berkorelasi secara signifikan terhadap variabel sindrom metabolik. Diversitas mikrobiota saluran cerna didapatkan menurun pada pasien NAFLD dengan trigliserida tinggi dan obesitas sentral.

Simpulan: Sejumlah mikrobiota saluran cerna pada tingkat taksonomi yang berbeda memiliki korelasi positif maupun negatif terhadap fibrosis dan steatosis.

---

Background: Non alcoholic fatty liver disease (NAFLD) is fatty liver condition that can lead to hepatocellular carcinoma (HCC). NAFLD is multifactorial component in its pathogenesis, one of which is gut microbiota. Dysbiosis of gut microbiota is considered as main factor in the dysregulation of immune system  and inflammatory condition in the pathogenesis of NAFLD.

Aim: This study aim to investigate the profile and configuration of gut microbiota in patient with NAFLD dan its correelation withfibrosis and steatosis condition as reflected in controlled attenuation parameter (CAP) dan transient elastography (TE) value.

Method: cross sectional study was done upon 37 NAFLD patients in Cipto Mangunkusumo National General Hospital from December 2018 to March 2019. All subjects undergone food recall examination, physical and laboratory examination, CAP-TE value measurement, and fecal sample examination. The gut microbiota was investigated through 16s RNA sequensing by Next-Generation Sequencing (NGS) platform Miseq (Illumina).

Result: NAFLD was predominant in female subjects and those with metabolic syndrome. Firmicutes, Bacteroidetes, dan Proteobacteria was the predominant phylum consecutively. Dysbiosis was appeared in half of the study subjects. The Ratio of Firmicutes/Bacteroidetes was different in each patients and has no significnat correlation with metabolic syndrome variables. The diversity of gut microbiota was decresed in NAFLD patients with high tryglicerides and central obesity.

Conclusion: Certain gut microbiota at different taxonomy level have positive and negative correlation with fibrosis and steeatosis.

"

"Latar Belakang. Keluarga derajat pertama (first degree relatives/FDR) dari Diabetes Melitus tipe 2 (DMT2) memiliki kecenderungan untuk memiliki gangguan metabolik dan vaskular lebih dini tanpa melaui resistensi insulin (RI) sebagai perantaranya seperti lebih tebalnya tunika intima media karotis. Penyakit perlemakan hati non-alkoholik (non-alcoholic fatty liver disease/NAFLD) adalah penyakit hati kronik yang banyak ditemukan pada pasien DMT2 yang dependen terhadap RI. Studi tentang hubungan FDR DMT2 dengan NAFLD masih sangat terbatas dan inkonklusif. Hubungan tersebut masih belum jelas apakah kejadian NAFLD pada FDR DMT2 dependen terhadap RI atau karena kerentanan genetik FDR DMT2. Tujuan. Untuk mengetahui hubungan antara FDR DMT2 dengan NAFLD. Metode. Sebanyak 118 dewasa muda (19-39 tahun) dengan toleransi glukosa normal (59 subjek FDR DMT2 dan 59 subjek non-FDR dengan matching usia dan jenis kelamin) diikutsertakan dalam penelitian potong lintang ini. Pengukuran antropometri (tinggi, berat badan, indeks massa tubuh (IMT) dan lingkar perut) dan analisis laboratorium (glukosa darah puasa, HbA1c, profil lipid, serum glutamic pyruvic transaminase (SGPT)), serum glutamic oxaloacetic transaminase (SGOT)) diperiksa pada penelitian ini. Perlemakan hati didiagnosis dengan ultrasonografi (USG) menggunakan kriteria standar. Hasil Penelitian. Dua puluh enam subjek (22,03%) dengan NAFLD terdeteksi dengan USG dalam penelitian ini dengan proporsi yang sama pada kedua kelompok. Pada kelompok FDR DMT2 didapatkan jumlah subjek dengan angka HDL rendah dan sindrom metabolik lebih tinggi dibandingkan dengan kelompok tanpa FDR. Kesimpulan. Pada penelitian ini tidak didapatkan hubungan antara FDR DMT2 dengan NAFLD.

---

Background. First degree relatives (FDR) of type 2 diabetes mellitus (T2DM) predisposes individuals to have earlier metabolic and vascular disorders independent of insulin resistance (IR) such as thicker carotid intima media thickness than that of non-FDR. Non-alcoholic fatty liver disease (NAFLD) is the most commonly found chronic liver disease in T2DM which is IR dependent. Studies about NAFLD in FDR of T2DM populations are very limited and inconclusive. It is unclear whether the occurrence of NAFLD in FDR of T2DM is IR dependent or due to genetic vulnerability.

Aim. to determine the association between NAFLD and FDR of T2DM.

Method. A total of 118 young adults (19-39 years old) with normal glucose tolerance (59 FDR of T2DM and age-sex matched 59 non-FDR subjects) were included in this cross-sectional study. Anthropometric measurement (height, weight, BMI and waist circumference) and routine laboratory analysis (fasting blood glucose, HbA1c, lipid profile, alanine aminotransferase (ALT), aspartate transaminase (AST)) were examined. Fatty liver was diagnosed by ultrasonography (US) using standard criteria.

Result. Twenty-six (22,03%) subjects with NAFLD were detected by US with similar proportion for each group. Low HDL level and metabolic syndrome were found higher in FDR group.

Conclusion. we couldn`t prove the association between FDR of T2DM and NAFLD in this research."

"Latar Belakang. Lean NAFLD lebih sering ditemukan di negara Asia dan prevalensinya di Indonesia masih belum diketahui. Tingginya prevalensi, asimptomatik dan baru bergejala setelah timbul komplikasi, dan tingginya mortalitas lean NAFLD menjadikan perlunya deteksi dini pada populasi dewasa dengan IMT <23 kg/m2. Skrining pada populasi umum tidak direkomendasikan karena meningkatkan biaya kesehatan.Tujuan. Membuat sistem skoring untuk penapisan lean NAFLD pada populasi dewasa di Jakarta.Metode. Studi ini menggunakan desain potong lintang dari laporan pemeriksaan kesehatan individu dewasa >18 tahun dengan IMT <23 kg/m2 yang melakukan pemeriksaan kesehatan di klinik. Parameter yang dianalisis antara lain usia, jenis kelamin, lingkar pinggang, kadar GDP, kolesterol total, HDL, LDL, trigliserida, AST, ALT, dan asam urat. Variabel dengan nilai p <0,25 dilanjutkan ke analisis multivariat untuk pembuatan sistem skoring.Hasil. Sebanyak 276 individu diikutsertakan pada penelitian ini dan didapatkan prevalensi lean NAFLD sebesar 9,8%. Lean NAFLD lebih banyak ditemukan pada laki-laki dan memiliki karakteristik usia lebih tua, IMT, lingkar pinggang, kadar GDP, ALT, dan trigliserida lebih tinggi dibanding lean tanpa NAFLD. Analisis bivariat mendapatkan jenis kelamin laki-laki, usia ≥45 tahun, kadar GDP ≥100 mg/dL, ALT ≥35 U/L, dan trigliserida ≥150 mg/dL berhubungan dengan lean NAFLD. Sistem skoring melibatkan 4 parameter yaitu laki-laki, kadar GDP ≥100 mg/dL, ALT ≥35 U/L, dan trigliserida ≥150 mg/dL dengan masing-masing bernilai 1 poin. Model skoring ini memiliki sensitivitas 44,4%, spesifisitas 84,3%, dan AUROC 0,74.Kesimpulan. Parameter jenis kelamin, kadar GDP, ALT, dan trigliserida dapat digunakan sebagai sistem skoring dengan performans menengah untuk penapisan lean NAFLD dewasa......Background. Lean NAFLD is commonly found in Asian countries and its prevalence in Indonesia is still unknown. The high prevalence, asymptomatic until complications occur, and the high mortality of lean NAFLD makes it necessary for early detection in adult with BMI <23 kg/m2. Screening in general population is not recommended due to the high cost burden.Aim. To develop a scoring system for screening lean NAFLD in adults in Jakarta Methods. A cross-sectional study design was conducted from medical examination reports from individual >18 years old and BMI <23 kg/m2 who performed medical check up at the clinic. Several parameters including age, gender, waist circumference (WC), fasting blood glucose (FBG), total cholesterol (TC), HDL, LDL, triglycerides (TG), AST, ALT, and uric acid (UA) were analyzed in this study. Variabels with p-value <0.25 were included in multivariate analysis for the development of scoring systems.Results. A total of 276 people were enrolled in this study. Prevalence of lean NAFLD is 9.8%. Lean NAFLD are more commonly found in men and have older age, higher BMI, WC, GDP, ALT, and TG levels than lean non-NAFLD. In bivariate analysis, male sex, age ≥ 45 years, FBG ≥100 mg/dL, ALT ≥35 U/L, and TG ≥150 mg/dL are associated with lean NAFLD. The scoring system involves four parameters including male, FBG ≥100 mg/dL, ALT ≥35 U/L, and TG ≥150 mg/dL, worth 1 point each. This model has sensitivity 44.4%, specificity 84.3%, and AUROC 0.74.Conclusion. Parameters including gender, FBG, ALT, and TG levels can be used as a scoring system with moderate performance for screening lean NAFLD in adults."

"ABSTRAKNon-alcoholic fatty liver disease (NAFLD) adalah penyakit hati kronik yang ditandai dengan akumulasi lemak berlebihan di hati. Elastografi Transien (ET) dan metode Controlled Attenuation Parameter (CAP) merupakan metode pemeriksaan non-invasif untuk menilai derajat fibrosis dan steatosis, namun tidak tersedia di seluruh rumah sakit di Indonesia. Rasio Neutrofil Limfosit (RNL) merupakan penanda peradangan sederhana yang berpotensi memprediksi luaran penyakit. Tujuan : Mengetahui nilai diagnostik RNL sebagai indikator derajat keparahan steatosis dan fibrosis NAFLD. Metode : Penelitian ini adalah studi potong lintang menggunakan data sekunder dari data rekam medis tahun 2016-2018. Analisis statistik deskriptif dan analitik berupa uji korelasi, Receiver Operating Curve (ROC) dan Area Under The Curve (AUC) dipakai untuk mengetahui luaran studi. Hasil : Dari 106 subjek penelitian, kebanyakan pasien adalah perempuan (62,3%) berusia rata-rata 57,29 tahun dan menderita sindrom metabolik (77,4%). Sebagian besar pasien memiliki derajat steatosis sedang-berat (66%) dengan rerata ET 6,14 (2,8-18,2). Terdapat korelasi antara nilai CAP (r=0,648; p<0,001) dan ET (r=0,621; p<0,001) dengan RNL. Penggunaan RNL untuk menilai derajat steatosis sedang-berat memiliki titik potong 1,775 dengan sensitivitas, spesifisitas, NDP dan NDN sebesar 81,5%, 80,6%, 89,1%, dan 69,1%; titik potong 2,150 untuk menilai fibrosis signifikan dengan sensitivitas, spesifisitas, NDP dan NDN berurutan sebesar 92,3 %; 87,5%; 70,6%; dan 97,2%. Simpulan : RNL memiliki korelasi positif dan signifikan terhadap derajat steatosis (CAP) dan fibrosis (ET) dengan sensitivitas dan spesifisitas yang cukup tinggi.

---

ABSTRACT

Non-alcoholic fatty liver disease (NAFLD) is a chronic inflammatory disease with excessive fat accumulation in the liver. Transient Elastography (TE) with Controlled Attenuation Parameter (CAP) is a device and method to examine the degree of fibrosis and steatosis. However, this device is not widely available across Indonesia. Neutrophil and Lymphocyte Ratio (NLR) is a simple marker for inflammation which has a potency to predict disease outcome. This study aims to know the diagnostic value of NLR as the indicator of steatosis and fibrosis severity. Methods: This was a cross-sectional study with consecutive sample collection. We used secondary data from medical record, starting from 2016-2018. A descriptive and analytic statistic, including correlation test, multivariate linear regression, t test, Receiver Operating Curve (ROC) and Area Under the Curve (AUC) were done to know the outcome of the study. Statistical analyses were performed using Statistical Package for Social Sciences (SPSS) Version 20.0 (SPSS Inc, Chicago, Illinois). A P value <0.05 was considered as statistically significant. Results: Out of 106 subjects, 62.3% patients were women with the mean of age 57.29 years old and 77.4% had metabolic syndrome. Most patients had moderate to severe steatosis degree (66%) with the mean of ET mean 6.14 (2.8-18.2). There was a positive correlation between CAP and TE compared with NLR with r=0.647 (p<0.001) and r=0.621 (p<0.001) respectively. The use of RNL to assess moderate-severe steatosis has a cutoff point of 1.775 with sensitivity,  specificity, PPV and NPV respectively at 81,5%, 80,6%, 89,1%, and 69,1%; cutoff point 2,150 to assess significant fibrosis with sensitivity, specificity, PPV and NPV of 92.3 %, 87.5%, 70.6%, and 97.2% respectively. Conclusion: NLR has a positive and significant correlation with the degree of steatosis and fibrosis with high sensitivity and specificity in comparison with TE/CAP."